Combination pairs OLAPLEX’s premium hair care brand with Henkel’s global reach and resources
Transaction is expected to accelerate OLAPLEX’s value creation and expand access to premium, science-led hair-health solutions for stylists and consumers
OLAPLEX stockholders to receive $2.06 per share
NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX” or “the Company”) (NASDAQ: OLPX), a premium hair care brand powered by science-led innovation and the professional hairstylist, today announced that it has entered into a definitive agreement to be acquired by Henkel AG & Co. KGaA (“Henkel”), a leading global manufacturer of well-known consumer and industrial brands, for $2.06 per share in a cash transaction, representing an equity value of approximately $1.4 billion. The transaction represents a premium of approximately 55% over OLAPLEX’s closing stock price on 3/25/2026 and a premium of approximately 45% over the volume weighted average price (VWAP) of OLAPLEX’s shares for the 30 trading days ended 3/25/2026.
Upon completion of the transaction, the Company will continue to operate under the OLAPLEX name and brand. OLAPLEX will no longer be listed on Nasdaq, and Advent International (“Advent”) will fully exit its investment in the Company at close.
The transaction is expected to:
Combine highly complementary strengths in the professional channel, where both companies have meaningful relationships with the stylist and salon community;Unlock new avenues for innovation through advanced technology, expanded capabilities and accelerated product development;Bring together OLAPLEX’s broad North American direct-to-consumer and specialty retail presence with Henkel’s international footprint, leading to expanded international reach; andCreate opportunities for innovation and growth, supported by OLAPLEX’s science-led approach and established position with consumers and Pro partners across demographics and hair needs. Amanda Baldwin, Chief Executive Officer of OLAPLEX, said, “Today marks an exciting next chapter for OLAPLEX. From our roots in the professional community to becoming one of the most trusted science-led brands in hair treatment, our journey has always been fueled by innovation and a deep commitment to stylists and consumers. This step is a testament to the momentum we’ve achieved in our transformation and the significant opportunities ahead for OLAPLEX to continue shaping the future of hair health and pursue long-term growth. I’m incredibly proud of what our team has accomplished and look forward to accelerating our product innovation, expanding our reach and continuing to deliver results for our Pro partners and customers around the world as part of the Henkel platform.”
John P. “JP” Bilbrey, Executive Chair of the OLAPLEX Board of Directors, added, “OLAPLEX’s growth reflects the strength of its science-led approach, its brand and the dedication of its team. We are proud to have supported Amanda and the entire OLAPLEX team as they drove brand momentum, scaled innovation and advanced significant operational transformation. We look forward to the opportunities ahead under Henkel’s stewardship.”
Since 2019, OLAPLEX has been backed by Advent, which helped scale the Company from a first-of-its-kind product to a science-led brand focused on hair health, supported by meaningful investments across product innovation, brand strength and operational excellence. The Company recently undertook a multi-year transformation program, which enhanced its innovation potential, marketing capabilities and go-to-market model and renewed engagement across stylist and consumer communities. As part of this, OLAPLEX also built out the people, processes and tools needed to drive executional excellence and efficiency on a global scale. These efforts, together with the Company’s science-led heritage and strong brand recognition, have positioned OLAPLEX well as it enters its next chapter under Henkel’s ownership.
Transaction Details
The transaction, which was approved by the OLAPLEX Board of Directors, is expected to close as soon as the second half of 2026, subject to regulatory approvals and other customary closing conditions. Advent, as holder of more than a majority of the voting power of the outstanding shares of OLAPLEX common stock, has approved the transaction by written consent. As a result, no further action by other OLAPLEX stockholders will be required to approve the transaction.
Advisors
J.P. Morgan Securities LLC is acting as financial advisor and Ropes & Gray LLP is serving as legal counsel to OLAPLEX.
About OLAPLEX
OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its first-of-its-kind Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX’s award-winning products are sold globally through an omnichannel model serving the professional, specialty retail and direct-to-consumer channels.
About Advent International
Advent is a leading global private equity investor committed to working in partnership with management teams, entrepreneurs, and founders to help transform businesses. With 16 offices across five continents, we oversee more than USD $100 billion in assets under management* and have made 448 investments across 44 countries.
Since our founding in 1984, we have developed specialist market expertise across our five core sectors: business & financial services, consumer, healthcare, industrial, and technology. This approach is bolstered by our deep sub-sector knowledge, which informs every aspect of our investment strategy, from sourcing opportunities to working in partnership with management to execute value creation plans. We bring hands-on operational expertise to enhance and accelerate businesses.
As one of the largest privately-owned partnerships, our 655 colleagues leverage the full ecosystem of Advent’s global resources, including our Portfolio Support Group, insights provided by industry expert Operating Partners and Operations Advisors, as well as bespoke tools to support and guide our portfolio companies as they seek to achieve their strategic goals.
To learn more, visit our website or connect with us on LinkedIn.
*Assets under management (AUM) as of September 30, 2025. AUM includes assets attributable to Advent advisory clients as well as employee and third-party co-investment vehicles.
Forward-Looking Statements
This press release includes forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, these forward-looking statements relate to analyses and other information that are based on beliefs, expectations, assumptions, and forecasts of future results. These forward-looking statements are identified by their use of terms and phrases, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms and phrases, including references to assumptions. Forward-looking statements include, without limitation, statements regarding the proposed transaction; the timing of and receipt of required regulatory filings and approvals relating to the transaction; the expected timing of the completion of the transaction; the ability to complete the transaction considering the various closing conditions; the potential benefits of the transaction, including the complementary strengths in the professional channel, ability to maximize scaled innovation, OLAPLEX’s direct-to-consumer and specialty retail presence, and opportunities for product development, geographic expansion; and the accuracy of any assumptions underlying any of the foregoing. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties. Risks and uncertainties that could cause the actual results to differ from expectations contemplated by forward-looking statements include: uncertainties as to the timing of the merger; the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, including circumstances requiring the Company to pay Parent a termination fee pursuant to the Merger Agreement; the ability of the parties to consummate the proposed transaction on a timely basis or at all; the satisfaction of the conditions precedent to the consummation of the proposed transaction, including the ability to secure regulatory approvals on the terms expected, at all or in a timely manner; the effects of the transaction (or the announcement or pendency thereof) on relationships with associates, customers, manufacturers, suppliers, employees (including the risks relating to the ability to retain or hire key personnel), other business partners or governmental entities; transaction costs; the risk that the merger will divert management’s attention from the Company’s ongoing business operations or otherwise disrupt the Company’s ongoing business operations; changes in the Company’s business during the period between now and the closing; certain restrictions during the pendency of the proposed transaction that may impact the Company’s ability to pursue certain business opportunities or strategic transactions; risks associated with litigation relating to the proposed transaction; the timing and outcome of anticipated interactions with regulatory authorities; risks related to the Company’s business, including the Company’s dependence on the success of its business transformation plan, competition in the beauty industry, the Company’s ability to effectively maintain and promote a positive brand image, expand its brand awareness and maintain consumer confidence in the quality, safety and efficacy of its products, and the Company’s ability to anticipate and respond to market trends and changes in consumer preferences and execute on its growth strategies and expansion opportunities, including with respect to new product introductions; and the other factors identified under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K filed with the SEC on March 5, 2026 and in the other documents that the Company files with the SEC from time to time. The forward-looking statements in this communication speak only as of the date of this communication. Olaplex undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by applicable law. The information set forth herein speaks only as of the date hereof.
No Offer or Solicitation
This press release is neither an offer to sell, nor a solicitation of an offer to buy any securities, the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transaction or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act and otherwise in accordance with applicable law.
Additional Information and Where to Find It
The Company will prepare and file an information statement on Schedule 14C for its stockholders with respect to the approval of the transaction described herein. When completed, the information statement will be mailed to the Company’s stockholders. You may obtain copies of all documents filed by the Company with the SEC regarding this transaction, free of charge, at the SEC’s website, www.sec.gov or from the Company website at https://ir.olaplex.com/sec-filings.
Company stockholders are urged to read all relevant documents filed with the SEC, including the Schedule 14C, as well as any amendments or supplements to these documents, carefully when they become available because they will contain important information about the transaction.
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data and the headline were updated in the story.)
U.S. stock futures fell on Thursday following Wednesday’s advances. Futures of the major benchmark indices were lower.
U.S. initial jobless claims rose to 210,000 for the week ending March 21, a modest increase of 5,000 from the previous week's unrevised level. Despite this slight uptick, the labor market showed signs of underlying resilience as the four-week moving average edged down to 210,500.
Highlighting this strength, insured unemployment fell by 32,000 to 1.819 million for the week ending March 14, marking its lowest level since May 2024.
In a post on Truth Social early Thursday, President Donald Trump described Iranian negotiators as "very different" and "strange," claiming they are "begging" for a deal despite publicly saying they are only "looking at our proposal." He warned that Iran “better get serious soon,” or there may be "no turning back,” cautioning that the outcome "won't be pretty."
This came after Trump said Wednesday that Iran was eager to reach a deal to end nearly four weeks of fighting, contradicting Iran’s foreign minister, who said Tehran was reviewing a U.S. proposal but had no plans to negotiate an end to the conflict.
Meanwhile, the 10-year Treasury bond yielded 4.37%, and the two-year bond was at 3.94%. The CME Group's FedWatch tool‘s projections show markets pricing a 93.8% likelihood of the Federal Reserve leaving the current interest rates unchanged in its April meeting.
IndexPerformance (+/-)Dow Jones-0.47%S&P 500-0.55%Nasdaq 100-0.65%Russell 2000-0.92%Stocks In FocusOlaplex Holdings Benzinga’s Edge Stock Rankings indicate that OLPX maintains a weak price trend over the long, short, and medium terms. FiscalNote Holdings Benzinga’s Edge Stock Rankings indicate that NOTE maintains a weak trend in the long, short, and medium terms. Worthington Steel Worthington Steel Inc. (NYSE:WS) plunged 14.04% after reporting weaker-than-expected third-quarter financial results. Benzinga’s Edge Stock Rankings indicate that WS maintains a weak price trend over the short, medium, and long terms, with a solid value score. MillerKnoll MillerKnoll Inc. (NASDAQ:MLKN) slumped 19.16% after reporting worse-than-expected third-quarter financial results and issuing weak fourth-quarter earnings guidance. Benzinga’s Edge Stock Rankings indicate that MLKN maintains a weak trend in the short, long, and medium terms, with a poor growth score. Benzinga’s Edge Stock Rankings indicate that PONY maintains a weak price trend in the short, medium, and long terms. Cues From Last SessionConsumer discretionary, materials, and health care stocks led the S&P 500 higher on Wednesday, while energy and real estate shares finished in the red.
Insights From AnalystsAccording to BlackRock's March 2026 commentary, the firm has downgraded U.S. stocks to neutral as escalating Middle East conflict creates a significant “macro shock.”
This geopolitical instability has triggered a “sharp repricing in energy markets,” leading to expectations of a prolonged supply disruption that could drag on global growth by approximately 0.75%.
BlackRock highlights a growing “market disconnect,” noting that current equity prices do not yet reflect the “macro damage that energy pricing implies.” While the S&P 500 remains near record highs, the firm warns that higher energy costs and uncertainty will soon weigh on demand.
Economically, the “energy shock has further weakened the case for the Fed’s easing rates this year.” Market expectations have shifted dramatically from anticipating three rate cuts to “veering toward a hike.”
BlackRock suggests that the window for Fed intervention is “closing fast” as persistent inflation and high debt burdens keep bond yields elevated. Consequently, they are “dialing down tactical risk,” remaining cautious until tangible evidence of de-escalation appears.
Upcoming Economic DataHere's what investors will be keeping an eye on Thursday.
Commodities, Crypto, And Global Equity MarketsCrude oil futures were trading lower in the early New York session by 3.55% to hover around $93.53 per barrel.
Gold Spot US Dollar fell 1.72% to hover around $4,428.84 per ounce. Its last record high stood at $5,595.46 per ounce. The U.S. Dollar Index spot was 0.08% higher at the 99.6820 level.
Meanwhile, Bitcoin (CRYPTO: BTC) was trading 0.50% higher at $71,238.02 per coin, as per the last 24 hours.
Asian markets closed lower on Thursday, except India’s Nifty 50 index. South Korea's Kospi, Japan's Nikkei 225, China’s CSI 300, Australia's ASX 200, and Hong Kong's Hang Seng indices fell. European markets were also lower in early trade.
Photo courtesy: Shutterstock
Market News and Data brought to you by Benzinga APIs
Olaplex (OLPX) surges 49% premarket after agreeing to a $1.4B all-cash acquisition by Henkel (HENKY), at a 55% premium to prior close. JetBlue (JBLU) gains 13% on reports of exploring a potential sale to major U.S. airlines, though discussions are preliminary.
German consumer brand Henkel announced Thursday that it has agreed to acquire all of prestige haircare brand Olaplex for $1.4 billion.
The company said the deal, at an offer price of $2.06 per share, was unanimously approved by Olaplex's board of directors and marks an "important milestone" in Henkel's business strategy.
"The planned acquisition of OLAPLEX is fully in line with Henkel's strategy to expand its portfolio through compelling, value-adding M&A activities," Henkel CEO Carsten Knobel said in a statement. "This transaction allows us to expand our presence in premium hair care. The brand creates compelling opportunities for future growth and innovation."
Henkel owns brands like Got2b and Purex.
Olaplex said the deal represented a premium of more than 50% over its closing stock price on Wednesday and would allow the company to explore new opportunities for innovation and growth, as well as expand its international reach.
"This step is a testament to the momentum we've achieved in our transformation and the significant opportunities ahead for OLAPLEX to continue shaping the future of hair health and pursue long-term growth," Olaplex CEO Amanda Baldwin said in a statement.
Shares of the company, which closed on Wednesday around $1.30 per share, shot up 50% following the announcement.
Olaplex had been struggling as a public company over the past few years, dealing with the fallout of a lawsuit alleging hair loss and increased competition in the prestige hair care space.
Prior to the deal, Olaplex's stock had lost nearly 95% of its value since its initial public offering in 2021, when it opened at $25 per share during a boom for IPOs. It had been trying to turn around its business, including by launching a new product last month and working to rewrite its reputation among consumers.
Analysts had previously told CNBC that they were excited at the prospect that the company may go private.
Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Ademi LLP is investigating Olaplex (NASDAQ: OLPX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Henkel.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, Olaplex stockholders will receive $2.06 per share in a cash transaction valued at approximately $1.4 billion. Olaplex insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Olaplex by imposing a significant penalty if Olaplex accepts a competing bid. We are investigating the conduct of the Olaplex board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Shares of Olaplex Holdings (OLPX) surged 50% on Thursday morning after the company agreed to be acquired by German consumer goods firm Henkel AG and Co. KGaA (HEN
Olaplex (OLPX 0.49%), a hair care treatment and protection specialist, closed Thursday at $2.01, up 51.13% for the session. The stock surged after news that German consumer goods behemoth Henkel agreed to acquire Olaplex for $2.06 per share in cash. Trading volume reached 104.6 million shares, about 2,904% above its three-month average of 3.5 million shares. Olaplex IPO'd in 2021 and has fallen 92% since going public.
How the markets moved todayS&P 500 fell 1.76% to finish Thursday at 6,476, while the Nasdaq Composite declined 2.38% to close at 21,408. Within personal care products, industry peers Estée Lauder Companies closed at $69.72, down 4.64%, and Procter & Gamble finished at $142.33, slipping 1.10% as investors reassessed sector growth prospects.
What this means for investorsOlaplex’s disappointing run as a publicly-traded company is coming to an end after the company agreed to be acquired for $2.06 per share in an all-cash deal with German consumer goods giant Henkel. The deal is worth $1.4 billion, far from Olaplex’s $15 billion market cap at its initial public offering in 2021.
When Olaplex first debuted on the market with its premium hair care products, it was growing sales by triple digits and boasted a 30% net profit margin. Since then, sales growth and profitability have turned negative, likely making the buyout a welcome relief. A relatively niche offering, Olaplex may be better suited in a broader portfolio of brands within Henkel rather than as a standalone company, so the deal makes sense to me.
Josh Kohn-Lindquist has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Olaplex Holdings, Inc. (NASDAQ: OLPX) related to its sale to Henkel US Operations Corporation. Under the terms of the proposed transaction, Olaplex shareholders are expected to receive $2.06 per share in cash. Is it a fair deal?
Click here for more info https://monteverdelaw.com/case/olaplex-holdings-inc/. It is free and there is no cost or obligation to you.
NOT ALL LAW FIRMS ARE EQUAL. Before you hire a law firm, you should talk to a lawyer and ask:
Do you file class actions and go to Court? When was the last time you recovered money for shareholders? What cases did you recover money in and how much? About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No one is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
Olaplex Holdings, Inc. (NASDAQ: OLPX - Get Free Report)'s share price hit a new 52-week high during trading on Thursday. The stock traded as high as $2.01 and last traded at $2.0050, with a volume of 71218940 shares changing hands. The stock had previously closed at $1.33. Key Headlines Impacting Olaplex Here are the key
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Olaplex Holdings, Inc. (NASDAQ: OLPX) to Henkel AG & Co. KGaA for $2.06 per share.Halper Sadeh encourages Olaplex shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected] investigation concerns whether Olaplex and its board of directors violated t.
Foxx Development (NASDAQ:FOXX – Get Free Report) and Olaplex (NASDAQ:OLPX – Get Free Report) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends.
Insider & Institutional Ownership 60.4% of Foxx Development shares are held by institutional investors. Comparatively, 87.4% of Olaplex shares are held by institutional investors. 31.6% of Foxx Development shares are held by company insiders. Comparatively, 4.3% of Olaplex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability This table compares Foxx Development and Olaplex’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Foxx Development -24.62% N/A -40.69% Olaplex -2.19% 1.07% 0.60% Earnings & Valuation This table compares Foxx Development and Olaplex”s gross revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Foxx Development $65.92 million 0.59 -$9.02 million ($2.26) -2.46 Olaplex $422.96 million 3.21 -$9.25 million ($0.01) -203.00 Foxx Development has higher earnings, but lower revenue than Olaplex. Olaplex is trading at a lower price-to-earnings ratio than Foxx Development, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk Foxx Development has a beta of -0.17, meaning that its stock price is 117% less volatile than the S&P 500. Comparatively, Olaplex has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500.
Analyst Recommendations This is a summary of recent ratings and target prices for Foxx Development and Olaplex, as reported by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Foxx Development 1 0 0 0 1.00 Olaplex 1 5 1 0 2.00 Olaplex has a consensus price target of $1.89, indicating a potential downside of 7.04%. Given Olaplex’s stronger consensus rating and higher possible upside, analysts plainly believe Olaplex is more favorable than Foxx Development.
Summary Olaplex beats Foxx Development on 11 of the 14 factors compared between the two stocks.
About Foxx Development (Get Free Report)
Foxx Development Holdings Inc. is a consumer electronics and integrated Internet-of-Things solution company catering to both retail and institutional clients. The company currently sells a diverse range of products including mobile phones, tablets and other consumer electronics devices principally in United State and is in the process of developing and distributing end-to-end communication terminals and IoT solutions. Foxx Development Holdings Inc., formerly known as Acri Capital Acquisition Corporation, is based in Austin, TX.
About Olaplex (Get Free Report)
Olaplex Holdings, Inc. develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company distributes its products through professional distributors in salons, directly to retailers for sale in their physical stores, e-commerce sites, and its website, Olaplex.com, as well as third party e-commerce platforms. The company was founded in 2014 and is based in Santa Barbara, California.
Receive News & Ratings for Foxx Development Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foxx Development and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEReviewing Alarm.com (NASDAQ:ALRM) and Brady (NYSE:BRC)
NEXT HEADLINE »Comparing Indaptus Therapeutics (NASDAQ:INDP) & Aldeyra Therapeutics (NASDAQ:ALDX)
BALA CYNWYD, Pa., April 02, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Olaplex Holdings, Inc. (“Olaplex” or the “Company”) (Nasdaq - OLPX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Henkel AG & Co. KGaA (“Henkel”) for $2.06 per share in a cash transaction, representing an equity value of approximately $1.4 billion.
The investigation concerns whether the Olaplex Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Gilead Sciences is paying fair value to shareholders of the Company.
If you own shares of Olaplex stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at [email protected], visit https://www.brodskysmith.com/cases/olaplex-holdings-inc-nasdaq-olpx/, or call toll free 855-576-4847.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olaplex Holdings, Inc. (NasdaqGS: OLPX) to Henkel AG & Co. KGaA. Under the terms of the proposed transaction, shareholders of Olaplex will receive $2.06 in cash for each share of Olaplex that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequ.
Alto Ingredients (NASDAQ:ALTO – Get Free Report) and Olaplex (NASDAQ:OLPX – Get Free Report) are both small-cap consumer discretionary companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.
Analyst Ratings This is a breakdown of recent ratings and recommmendations for Alto Ingredients and Olaplex, as provided by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alto Ingredients 0 1 0 1 3.00 Olaplex 1 5 1 0 2.00 Olaplex has a consensus price target of $1.89, indicating a potential downside of 7.04%. Given Olaplex’s higher probable upside, analysts clearly believe Olaplex is more favorable than Alto Ingredients.
Valuation and Earnings This table compares Alto Ingredients and Olaplex”s top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alto Ingredients $917.93 million 0.39 $13.34 million $0.16 29.19 Olaplex $422.96 million 3.21 -$9.25 million ($0.01) -203.00 Alto Ingredients has higher revenue and earnings than Olaplex. Olaplex is trading at a lower price-to-earnings ratio than Alto Ingredients, indicating that it is currently the more affordable of the two stocks.
Profitability This table compares Alto Ingredients and Olaplex’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Alto Ingredients 1.45% 2.99% 1.69% Olaplex -2.19% 1.07% 0.60% Risk & Volatility Alto Ingredients has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500. Comparatively, Olaplex has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500.
Insider & Institutional Ownership 42.4% of Alto Ingredients shares are held by institutional investors. Comparatively, 87.4% of Olaplex shares are held by institutional investors. 5.3% of Alto Ingredients shares are held by insiders. Comparatively, 4.3% of Olaplex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Summary Alto Ingredients beats Olaplex on 10 of the 15 factors compared between the two stocks.
About Alto Ingredients (Get Free Report)
Alto Ingredients, Inc. produces, distributes, and markets specialty alcohols, renewable fuel, and essential ingredients in the United States. The company operates in three segments: Marketing and Distribution, Pekin Campus Production, and Western Production. It offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners for health, home, and beauty markets; grain neutral spirits used in alcoholic beverages and vinegar, as well as corn germ used in corn oils in the food and beverage markets; alcohols and other products for paint applications and fertilizers in the industrial and agriculture markets; and essential ingredients include dried yeast, corn protein meal, corn protein feed, distiller's grains, and liquid feed for commercial animal feed and pet food applications, as well as yeast for human consumption. The company also provides fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, it offers transportation, storage, and delivery services through third-party service providers. The company sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry, renewable diesel, and biodiesel customers. It operates alcohol production facilities. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc. in January 2021. Alto Ingredients, Inc. was founded in 2003 and is headquartered in Pekin, Illinois.
About Olaplex (Get Free Report)
Olaplex Holdings, Inc. develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers. The company distributes its products through professional distributors in salons, directly to retailers for sale in their physical stores, e-commerce sites, and its website, Olaplex.com, as well as third party e-commerce platforms. The company was founded in 2014 and is based in Santa Barbara, California.
Receive News & Ratings for Alto Ingredients Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alto Ingredients and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEComparing United Internet (OTCMKTS:UDIRF) and LivePerson (NASDAQ:LPSN)
NEXT HEADLINE »Reviewing Primoris Services (NYSE:PRIM) and SOLV Energy (NASDAQ:MWH)
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Olaplex (NASDAQ: OLPX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Henkel.
Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.
In the transaction, Olaplex stockholders will receive $2.06 per share in a cash transaction valued at approximately $1.4 billion. Olaplex insiders will receive substantial benefits as part of change of control arrangements.
The transaction agreement unreasonably limits competing transactions for Olaplex by imposing a significant penalty if Olaplex accepts a competing bid. We are investigating the conduct of the Olaplex board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
State of Alaska Department of Revenue cut its stake in Olaplex Holdings, Inc. (NASDAQ:OLPX – Free Report) by 47.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 606,213 shares of the company’s stock after selling 549,497 shares during the quarter. State of Alaska Department of Revenue owned about 0.09% of Olaplex worth $810,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in OLPX. Chilton Capital Management LLC acquired a new position in shares of Olaplex during the third quarter worth about $26,000. Schonfeld Strategic Advisors LLC acquired a new position in shares of Olaplex during the third quarter worth about $30,000. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Olaplex during the third quarter worth about $32,000. BNP Paribas Financial Markets lifted its stake in shares of Olaplex by 95.4% during the third quarter. BNP Paribas Financial Markets now owns 29,707 shares of the company’s stock worth $39,000 after purchasing an additional 14,507 shares in the last quarter. Finally, Savant Capital LLC acquired a new stake in Olaplex in the third quarter valued at approximately $43,000. 87.37% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth OLPX has been the subject of several recent research reports. Jefferies Financial Group reaffirmed a “buy” rating on shares of Olaplex in a research report on Wednesday, March 4th. Northland Securities downgraded shares of Olaplex from a “strong-buy” rating to a “hold” rating in a research report on Thursday, March 26th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Olaplex in a research report on Thursday, January 22nd. Zacks Research upgraded shares of Olaplex from a “strong sell” rating to a “hold” rating in a report on Thursday, February 19th. Finally, Telsey Advisory Group boosted their price objective on shares of Olaplex from $2.00 to $2.06 and gave the stock a “market perform” rating in a report on Friday, March 27th. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Olaplex currently has an average rating of “Hold” and a consensus target price of $1.92.
View Our Latest Stock Analysis on Olaplex
Insider Activity at Olaplex In related news, insider Trisha L. Fox sold 25,421 shares of the company’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $32,030.46. Following the sale, the insider directly owned 1,080,363 shares of the company’s stock, valued at $1,361,257.38. This represents a 2.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel John C. Duffy sold 34,962 shares of the company’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $1.26, for a total transaction of $44,052.12. Following the completion of the sale, the general counsel directly owned 982,855 shares in the company, valued at $1,238,397.30. This represents a 3.43% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 215,442 shares of company stock valued at $271,457 over the last ninety days. Corporate insiders own 4.30% of the company’s stock.
Olaplex Price Performance Shares of NASDAQ OLPX opened at $2.03 on Thursday. Olaplex Holdings, Inc. has a fifty-two week low of $0.99 and a fifty-two week high of $2.04. The business has a 50 day moving average price of $1.68 and a two-hundred day moving average price of $1.44. The company has a quick ratio of 4.00, a current ratio of 4.58 and a debt-to-equity ratio of 0.40. The firm has a market cap of $1.36 billion, a PE ratio of -203.00 and a beta of 2.01.
Olaplex (NASDAQ:OLPX – Get Free Report) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.01 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.01. The firm had revenue of $105.12 million during the quarter, compared to analyst estimates of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.Olaplex’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.01 EPS. Sell-side analysts expect that Olaplex Holdings, Inc. will post 0.09 earnings per share for the current fiscal year.
About Olaplex (Free Report)
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Recommended Stories Five stocks we like better than Olaplex
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINESterling Infrastructure, Inc. $STRL Position Trimmed by State of Alaska Department of Revenue
NEXT HEADLINE »GB Group’s (GBG) “Buy” Rating Reaffirmed at Shore Capital Group
NEW YORK, NY, May 11, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the first quarter ended March 31, 2026.
Amanda Baldwin, OLAPLEX’s Chief Executive Officer, commented: "We delivered a solid start to the year with positive quarterly sell-through led by the successful launch of No. 3 PLUS. Through the disciplined operational execution of our transformation priorities, our higher sales translated to a strong quarter. I want to again thank the entire Olaplex team for their continued dedication and commitment to our transformation."
For the first quarter of 2026 compared to the first quarter of 2025:
Net sales increased 2.5% to $99.4 million; By channel: Specialty Retail decreased 13.3% to $33.4 million;Professional increased 12.3% to $38.8 million;Direct-To-Consumer increased 13.8% to $27.2 million; Net sales decreased 3.5% in the United States and increased 8.6% internationally; Net loss was $5.3 million, as compared to net income of $0.5 million for the first quarter of 2025;Diluted net loss per share was $(0.01), as compared to $0.00 for the first quarter of 2025. Three Months Ended March 31, 2026 Results
(Amounts in thousands, except per share and share data) Three Months Ended March 31, 2026 2025 % ChangeNet Sales $99,369 $96,978 2.5%Gross Profit $71,660 $67,356 6.4%Gross Profit Margin 72.1% 69.5% Adjusted Gross Profit $74,076 $69,748 6.2%Adjusted Gross Profit Margin 74.5% 71.9% SG&A $65,951 $47,987 37.4%Adjusted SG&A $55,038 $44,349 24.1%Net (Loss) Income $(5,287) $465 (1,237.0)%Adjusted Net Income $10,648 $13,161 (19.1)%Adjusted EBITDA $18,978 $25,664 (26.1)%Adjusted EBITDA Margin 19.1% 26.5% Diluted Net Loss Per Share $(0.01) $0.00 —%Adjusted Diluted Net Income Per Share $0.02 $0.02 —%
Adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted net income, adjusted EBITDA, adjusted EBITDA margin and adjusted diluted net income per share are measures that are not calculated or presented in accordance with generally accepted accounting principles in the United States of America ("GAAP"). For more information about how we use these non-GAAP financial measures in our business, the limitations of these measures, and a reconciliation of these measures to the most directly comparable GAAP measures, please see "Disclosure Regarding Non-GAAP Financial Measures" and the reconciliation tables that accompany this release.
Balance Sheet
As of March 31, 2026, the Company had $326.2 million of cash and cash equivalents, compared to $318.7 million as of December 31, 2025. Inventory at the end of the first quarter of 2026 was $66.4 million, compared to $60.2 million at December 31, 2025. Long-term debt, net of current portion and deferred debt issuance costs was $352.5 million as of March 31, 2026, compared to $352.3 million as of December 31, 2025.
Fiscal Year 2026 Guidance, Webcast and Conference Call Information
On March 26, 2026, OLAPLEX announced that it had entered into a definitive agreement to be acquired by Henkel AG & Co. KGaA (“Henkel”), a leading global manufacturer of well-known consumer and industrial brands, for $2.06 per share in a cash transaction, representing an equity value of approximately $1.4 billion. The transaction represents a premium of approximately 55% over OLAPLEX’s closing stock price on March 25, 2026 and a premium of approximately 45% over the volume weighted average price of OLAPLEX’s shares for the 30 trading days ended March 25, 2026.
In light of the transaction, OLAPLEX will not host a conference call to discuss its first quarter 2026 results and will not be providing or updating previously issued financial guidance.
About OLAPLEX
OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX’s award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
This press release includes certain forward-looking statements and information relating to the Company that are based on the beliefs of management as well as assumptions made by, and information currently available to, the Company. These forward-looking statements include, but are not limited to, statements about: the proposed transaction (the “Merger”) with Henkel; the Company’s business transformation plans; and other statements contained in this press release that are not historical or current facts. When used in this press release, words such as "may," "will," “could," "should," "intend," "potential," "continue," "anticipate," "believe," "estimate," "expect," "plan," "target," "predict," "project," "forecast," "seek" and similar expressions as they relate to the Company are intended to identify forward-looking statements.
The forward-looking statements in this press release reflect the Company’s current expectations and projections about future events and financial trends that management believes may affect the Company’s business, financial condition and results of operations. These statements are predictions based upon assumptions that may not prove to be accurate, and they are not guarantees of future performance. As such, you should not place significant reliance on the Company’s forward-looking statements. Neither the Company nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements, including any such statements taken from third party industry and market reports.
Forward-looking statements involve known and unknown risks, inherent uncertainties and other factors that are difficult to predict which may cause the Company’s actual results, performance, time frames or achievements to be materially different from any future results, performance, time frames or achievements expressed or implied by the forward-looking statements, including, without limitation: uncertainties as to the timing or completion of the Merger, including the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement with Henkel (the “Merger Agreement”) and circumstances requiring the Company to pay a termination fee or damages under the Merger Agreement; the effects of the proposed Merger (or the announcement or pendency thereof) on relationships with associates, customers, manufacturers, suppliers, employees (including the risks relating to the ability to retain or hire key personnel), other business partners or governmental entities; the risk that the proposed Merger will divert management's attention from the Company's ongoing business operations or otherwise disrupt the Company's ongoing business operations; risks associated with litigation relating to the proposed Merger; the Company’s dependence on the success of its business transformation plan; competition in the beauty industry; the Company’s ability to effectively maintain and promote a positive brand image, expand its brand awareness and maintain consumer confidence in the quality, safety and efficacy of its products; the Company’s ability to anticipate and respond to market trends and changes in consumer preferences and execute on its growth strategies and expansion opportunities, including with respect to new product introductions; the Company’s ability to develop, manufacture and effectively and profitably market and sell future products; the Company’s ability to attract new customers and consumers and encourage consumer spending across its product portfolio; the Company’s ability to successfully implement new or additional marketing efforts; the Company’s relationships with and the capabilities and performance of its suppliers, manufacturers, distributors and retailers and the Company’s ability to manage its supply chain, including sourcing, manufacturing and quality control; the Company's dependence on a limited number of customers for a large portion of its net sales; the Company’s ability to limit the illegal distribution and sale by third parties of counterfeit versions of its products or the unauthorized diversion by third parties of its products; the Company’s ability to accurately forecast customer and consumer demand for its products; impacts on the Company’s business from political, regulatory, economic, trade and other risks associated with operating internationally; the Company’s ability to attract and retain senior management and other qualified personnel; the Company’s reliance on its and its third-party service providers’ information technology; the Company’s ability to maintain the security of confidential information; the Company’s ability to establish and maintain intellectual property protection for its products, as well as the Company’s ability to operate its business without infringing, misappropriating or otherwise violating the intellectual property rights of others; the outcome of litigation and regulatory proceedings; the impact of changes in federal, state and international laws, regulations and administrative policy, tariffs and other trade policies; the Company’s existing and any future indebtedness, including the Company’s ability to comply with affirmative and negative covenants under its credit agreement; the Company’s ability to service its existing indebtedness and obtain additional capital to finance operations and its growth opportunities; volatility of the Company’s stock price; the Company’s “controlled company” status and the influence of investment funds affiliated with Advent International, L.P. over the Company; the impact of general economic conditions, disruptions in business conditions, and the financial strength of the Company’s consumers and customers on the Company’s business; fluctuations in the Company’s quarterly results of operations; changes in the Company’s tax rates and the Company’s exposure to tax liability; the Company's ability to integrate or realize the intended benefits of its acquisitions or strategic investments; and the other factors identified under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") and in the other documents that the Company files with the SEC from time to time.
Many of these factors are macroeconomic in nature and are, therefore, beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in this press release as anticipated, believed, estimated, expected, intended, planned or projected. The forward-looking statements in this press release represent management’s views as of the date hereof. Unless required by law, the Company neither intends nor assumes any obligation to update these forward-looking statements for any reason after the date hereof to conform these statements to actual results or to changes in the Company’s expectations or otherwise.
Disclosure Regarding Non-GAAP Financial Measures
In addition to the financial measures presented in this release in accordance with GAAP, the Company has included certain non-GAAP financial measures, including adjusted EBITDA, adjusted EBITDA margin, adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted net income and adjusted basic and diluted net income per share. Management believes these non-GAAP financial measures, when taken together with the Company’s financial results presented in accordance with GAAP, provide meaningful supplemental information regarding the Company’s operating performance and facilitate internal comparisons of its historical operating performance on a more consistent basis by excluding certain items that may not be indicative of its business, results of operations or outlook. In particular, management believes that the use of these non-GAAP measures may be helpful to investors as they are measures used by management in assessing the health of the Company’s business, determining incentive compensation and evaluating its operating performance, as well as for internal planning and forecasting purposes.
The Company calculates adjusted EBITDA as net income (loss), adjusted to exclude: (1) interest expense, net; (2) income tax (benefit) provision; (3) depreciation and amortization; (4) share-based compensation expense; (5) certain litigation-related expenses and (6) Merger transaction-related costs. The Company calculates adjusted EBITDA margin by dividing adjusted EBITDA by net sales. The Company calculates adjusted gross profit as gross profit, adjusted to exclude amortization of patented formulations. The Company calculates adjusted gross profit margin by dividing adjusted gross profit by net sales. The Company calculates adjusted SG&A as SG&A, adjusted to exclude: (1) share-based compensation expense, (2) certain litigation-related expenses and (3) Merger transaction-related costs. The Company calculates adjusted net income as net income (loss), adjusted to exclude: (1) amortization of intangible assets (excluding software); (2) share-based compensation expense; (3) certain litigation-related expenses; (4) Merger transaction-related costs; and (5) tax effect of non-GAAP adjustments. The Company calculates adjusted basic and diluted net income per share as adjusted net income divided by weighted average basic and diluted shares outstanding, respectively. Please refer to "Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents" located in the financial supplement in this release for further information regarding these adjustments for the periods presented.
Please refer to "Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents" located in the financial supplement in this release for a reconciliation of these non-GAAP metrics to their most directly comparable financial measure stated in accordance with GAAP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands, except per share and share data)
(Unaudited)
March 31,
2026 December 31,
2025Assets Current Assets: Cash and cash equivalents$326,169 $318,731 Accounts receivable, net of allowances of $14,503 and $18,123 37,501 29,013 Inventory 66,364 60,215 Prepaid expenses and other current assets 16,227 62,387 Total current assets 446,261 470,346 Property and equipment, net 1,516 1,422 Intangible assets, net 834,864 847,821 Goodwill 168,300 168,300 Deferred tax assets — 46 Other assets 9,253 9,552 Total assets$1,460,194 $1,497,487 Liabilities and stockholders’ equity Current Liabilities: Accounts payable$29,184 $8,117 Accrued expenses and other current liabilities 32,758 85,304 Current portion of Related Party payable pursuant to Tax Receivable Agreement 9,206 9,206 Total current liabilities 71,148 102,627 Long-term debt 352,484 352,290 Deferred tax liabilities 929 5,283 Related Party payable pursuant to Tax Receivable Agreement 155,858 155,858 Other liabilities 1,789 2,039 Total liabilities 582,208 618,097 Commitments and Contingencies Stockholders’ equity: Common stock, $0.001 par value per share; 2,000,000,000 shares authorized, 671,711,593 and 669,076,651 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 672 669 Preferred stock, $0.001 par value per share; 25,000,000 shares authorized and no shares issued and outstanding — — Additional paid-in capital 346,086 342,345 Accumulated other comprehensive loss (198) (337)Retained earnings 531,426 536,713 Total stockholders’ equity 877,986 879,390 Total liabilities and stockholders’ equity$1,460,194 $1,497,487 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
(amounts in thousands, except per share and share data)
(Unaudited)
Three Months Ended
March 31, 2026 2025 Net sales$99,369 $96,978 Cost of sales: Cost of product (excluding amortization) 25,293 27,230 Amortization of patented formulations 2,416 2,392 Total cost of sales 27,709 29,622 Gross profit 71,660 67,356 Operating expenses: Selling, general, and administrative 65,951 47,987 Amortization of other intangible assets 10,820 10,893 Total operating expenses 76,771 58,880 Operating (loss) income (5,111) 8,476 Interest expense 7,132 13,725 Interest income (2,702) (5,952)Other expense (income), net 142 (178)(Loss) Income before provision for income taxes (9,683) 881 Income tax (benefit) provision (4,396) 416 Net (loss) income$(5,287) $465 Net (loss) income per share: Basic$(0.01) $0.00 Diluted$(0.01) $0.00 Weighted average common shares outstanding: Basic 669,942,446 664,685,462 Diluted 669,942,446 666,460,714 Other comprehensive income: Unrealized gain on derivatives, net of income tax effect$139 $17 Total other comprehensive income 139 17 Comprehensive (loss) income$(5,148) $482 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(amounts in thousands)
(Unaudited)
Three Months Ended
March 31, 2026 2025 Cash flows from operating activities Net (loss) income$(5,287) $465 Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities 12,786 (3,382)Net cash provided by (used in) operating activities 7,499 (2,917)Net cash used in investing activities (288) (996)Net cash provided by (used in) financing activities 227 (1,161)Net increase (decrease) in cash and cash equivalents 7,438 (5,074)Cash and cash equivalents - beginning of year 318,731 585,967 Cash and cash equivalents - end of period$326,169 $580,893 Reconciliation of Non-GAAP Financial Measures to GAAP Equivalents
(amounts in thousands, except per share and share data)
(Unaudited) The following tables present a reconciliation of net (loss) income, gross profit and SG&A, as the most directly comparable financial measure stated in accordance with U.S. GAAP, to adjusted EBITDA, adjusted EBITDA margin, adjusted gross profit, adjusted gross profit margin, adjusted SG&A, adjusted net income and adjusted net income per share for each of the periods presented.
Three Months Ended
March 31, 2026 2025 Reconciliation of Net (Loss) Income to Adjusted EBITDA Net (loss) income$(5,287) $465 Depreciation and amortization of intangible assets 13,318 13,372 Interest expense, net 4,430 7,773 Income tax (benefit) provision (4,396) 416 Share-based compensation expense 3,517 2,918 Certain litigation-related expenses(1) — 720 Merger transaction-related costs(2) 7,396 — Adjusted EBITDA$18,978 $25,664 Adjusted EBITDA margin 19.1% 26.5% Three Months Ended
March 31, 2026 2025 Reconciliation of Gross Profit to Adjusted Gross Profit Gross profit$71,660 $67,356 Amortization of patented formulations 2,416 2,392 Adjusted gross profit$74,076 $69,748 Adjusted gross profit margin 74.5% 71.9% Three Months Ended
March 31, 2026 2025 Reconciliation of SG&A to Adjusted SG&A SG&A$65,951 $47,987 Share-based compensation expense (3,517) (2,918)Certain litigation-related expenses(1) — (720)Merger transaction-related costs(2) (7,396) — Adjusted SG&A$55,038 $44,349 Three Months Ended
March 31, 2026 2025 Reconciliation of Net (Loss) Income to Adjusted Net Income Net (loss) income$(5,287) $465 Amortization of intangible assets (excluding software) 12,599 12,574 Share-based compensation expense 3,517 2,918 Certain litigation-related expenses(1) — 720 Merger transaction-related costs(2) 7,396 — Tax effect of adjustments (7,577) (3,516)Adjusted net income$10,648 $13,161 Adjusted net income per share: Basic$0.02 $0.02 Diluted$0.02 $0.02 Weighted average diluted shares outstanding(3) 674,802,028 666,460,714 (1)Represented litigation costs related to the Lilien securities class action. The Company considers litigation costs related to the Lilien securities class action, as described in Note 12 to the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2026, to be non-recurring and non-ordinary. The Company believes adjusting for such costs provides investors with meaningful information regarding the Company’s core operating performance.(2)Represents non-recurring and non-ordinary costs related to the definitive agreement to be acquired by Henkel. (3)Weighted average diluted shares outstanding for the three months ended March 31, 2026 differ from the GAAP presentation on the Company's Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income due to the Company being in a loss position on an unadjusted basis. Contacts:
For the quarter ended March 2026, Olaplex Holdings, Inc. (OLPX - Free Report) reported revenue of $99.37 million, up 2.5% over the same period last year. EPS came in at $0.02, compared to $0 in the year-ago quarter.
The reported revenue represents a surprise of +6.1% over the Zacks Consensus Estimate of $93.66 million. With the consensus EPS estimate being $0.01, the EPS surprise was +42.86%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Olaplex performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Professional: $38.79 million versus $35.26 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +12.4% change.Revenue- DTC: $27.17 million versus the five-analyst average estimate of $23.97 million. The reported number represents a year-over-year change of +13.7%.Revenue- Specialty retail: $33.41 million versus $35.26 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -13.4% change.View all Key Company Metrics for Olaplex here>>>
Shares of Olaplex have returned +0.7% over the past month versus the Zacks S&P 500 composite's +9.1% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.
NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today released the following pursuant to an Order of the U.S. District Court for the Central District of California.
UNITED STATES DISTRICT COURT
CENTRAL DISTRICT OF CALIFORNIA
IN RE OLAPLEX HOLDINGS, INC. STOCKHOLDER DERIVATIVE LITIGATION Lead Case No.: 2:23-cv-09712-SVW-SKThis Document Relates To: ALL ACTIONS.
NOTICE OF PENDENCY AND PROPOSED SETTLEMENT
OF STOCKHOLDER DERIVATIVE MATTERS
AND SETTLEMENT HEARING
TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF OLAPLEX HOLDINGS INC. (“OLAPLEX” OR THE “COMPANY”) COMMON STOCK (TICKER SYMBOL: OLPX) AS OF APRIL 24, 2026, WHO CONTINUE TO OWN SUCH SHARES (“CURRENT OLAPLEX SHAREHOLDERS”).
PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE OF SHAREHOLDER DERIVATIVE LITIGATION AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS.
YOUR RIGHTS MAY BE AFFECTED.
IF THE COURT APPROVES THE SETTLEMENT AND DISMISSAL OF THE DERIVATIVE MATTERS, OLAPLEX SHAREHOLDERS WILL BE FOREVER BARRED FROM CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND DISMISSAL WITH PREJUDICE, AND FROM PURSUING PLAINTIFFS’ RELEASED CLAIMS.
THIS ACTION IS NOT A “CLASS ACTION.” THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY PAYMENT.
On April 24, 2026, Plaintiffs, nominal defendant Olaplex, Advent International Corporation, and the Individual Defendants entered into a Stipulation and Agreement of Settlement (the “Stipulation”) to settle: the shareholder derivative actionsi styled Ciuffo v. Dagousset, et al., Case No. 2:23-cv-09712-SVW-SK and Hutchinson v. Advent International Corporation, et al., Case No. 2:24-cv-02364, consolidated as In re Olaplex Holdings, Inc. Stockholder Derivative Litigation, Lead Case No. 2:23-cv-09712-SVW-SK (the “Consolidated Derivative Action”), filed derivatively on behalf of Olaplex and pending in the United States District Court for the Central District of California (the “Court”); and the Section 220 demand for inspection of the Company’s books and records made by stockholder Kajeel Patel (the “Demand” and with the Consolidated Derivative Action, the “Derivative Matters”).ii The Settlement, which is subject to the approval of the Court, is intended by the Parties to fully, finally, and forever compromise, settle, release, resolve, and dismiss with prejudice the Released Claims upon and subject to the terms and conditions set forth in the Stipulation. The proposed Settlement requires the Company to adopt certain corporate governance reforms (“Reforms”), as outlined in Exhibit A to the Stipulation, and provides that Defendants shall cause their insurers to pay an agreed-to Fee and Expense Amount to Plaintiffs’ Counsel of $700,000, subject to Court approval, and that Plaintiffs’ Counsel may also move the Court to approve Service Awards to each of the three Plaintiffs, to be paid from the Fee and Expense Amount, in the amount of two thousand five hundred dollars ($2,500.00) each.
This Notice is a summary only and does not describe all of the details of the Stipulation. For full details of the matters discussed in this summary, please see the full Stipulation by visiting the SEC Filings portion of Olaplex’s website at https://ir.olaplex.com/sec-filings/all-sec-filings, reviewing Olaplex’s U.S. Securities and Exchange Commission (“SEC”) filings, contacting Plaintiffs’ Counsel at the addresses listed below, or inspecting the full Stipulation filed with the Clerk of the Court.
Summary
On May 7, 2026, the Court entered an order preliminarily approving the Stipulation and the Settlement contemplated therein (the “Preliminary Approval Order”) and providing for the notice of the Settlement to be disseminated to Current Olaplex Shareholders. The Preliminary Approval Order further provides that the Court will hold a hearing (the “Settlement Hearing”) on July 27, 2026 at 1:30 p.m. before the Honorable Stephen V. Wilson, in Courtroom 10A of the First Street United States Courthouse, 350 West 1st Street, Suite 4311 Los Angeles, CA 90012-4565, with the discretion to proceed telephonically or remotely, to, among other things: (i) determine whether the proposed Settlement is fair, reasonable, and adequate and in the best interests of the Company and its shareholders; (ii) consider any objections to the Settlement submitted in accordance with this Notice; (iii) determine whether a judgment should be entered dismissing all claims in the Consolidated Derivative Action with prejudice, and releasing Plaintiffs’ Released Claims against Defendants’ Released Persons (the “Judgment”); (iv) consider the payment to Plaintiffs’ Counsel of attorneys’ fees and expenses; (v) consider the payment of Service Awards to the three Plaintiffs, which shall be funded from the attorneys’ fees and expenses awarded by the Court; and (vi) consider any other matters that may properly be brought before the Court in connection with the Settlement. Upon final approval of the Settlement, the Demand will be withdrawn.
Upon the Effective Date, Olaplex, Plaintiffs, and each of the Current Olaplex Shareholders shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged their right to assert derivatively on behalf of the Company any and all of Plaintiffs’ Released Claims (including Unknown Claims) against Defendants’ Released Persons, and shall be permanently barred and enjoined from instituting, commencing, or prosecuting derivatively on behalf of the Company any and all of Plaintiffs’ Released Claims against the Defendants’ Released Persons. In addition, upon that date, Olaplex shall be deemed to have, and by operation of the law and of the Judgment shall have, fully, finally, and forever released, relinquished and discharged its right to assert directly any and all of Plaintiffs’ Released Claims against Defendants’ Released Persons, and shall be permanently barred and enjoined from instituting, commencing, or prosecuting any of Plaintiffs’ Released Claims against Defendants’ Released Persons except to enforce the releases and other terms and conditions contained in this Stipulation and/or the Judgment entered pursuant thereto.
Upon the Effective Date, Defendants shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged each any and all of Defendants’ Released Claims against Plaintiffs’ Released Persons. Defendants shall be deemed to have, and by operation of the Judgment shall have, covenanted not to sue Plaintiffs’ Released Persons with respect to any of Defendants’ Released Claims, and shall be permanently barred and enjoined from instituting, commencing, or prosecuting any Defendants’ Released Claims against Plaintiffs’ Released Persons except to enforce the releases and other terms and conditions contained in this Stipulation and/or the Judgment entered pursuant thereto.
Why is there a Settlement?
The Court has not decided in favor of Defendants or Plaintiffs. Instead, the Parties agreed to the Settlement to avoid the distraction, costs, and risks of further litigation. The Parties also agree that the Reforms confer significant benefits to Olaplex and Olaplex’s shareholders.
Defendants have denied, and continue to deny, each and every claim and contention alleged by Plaintiffs in the Derivative Matters and affirm that they have acted properly, lawfully, and in full accord with their fiduciary duties, at all times. Further, Defendants have denied expressly, and continue to deny, all allegations of wrongdoing, fault, liability, or damage against them arising out of any of the conduct, statements, acts, or omissions alleged, or that could have been alleged, in the Derivative Matters and deny that they have ever committed or attempted to commit any violations of law, any breach of fiduciary duty owed to Olaplex or its shareholders, or any wrongdoing whatsoever. Defendants further deny that Olaplex has suffered any damage, injury, or other harm as a result of any action or inaction on their part. Had the terms of this Stipulation not been reached, Defendants assert that they would have continued to contest vigorously Plaintiffs’ allegations, and Defendants maintain that they had and have meritorious defenses to all claims alleged in the Derivative Matters. Without admitting the validity of any of the claims that Plaintiffs have asserted in the Derivative Matters, or any liability with respect thereto, Defendants have determined that it is desirable that the claims be settled on the terms and subject to the conditions set forth herein.
The Settlement Hearing and Your Right to Object to the Settlement
Any Current Olaplex Shareholder who wishes to object to the fairness, reasonableness, or adequacy of the Settlement as set forth in the Stipulation, or to the proposed award of attorneys’ fees and expenses, may file with the Court a written objection. At least twenty-one (21) days prior to the Settlement Hearing, an objector must: (1) file with the Clerk of the Court and serve upon the below listed counsel a written objection to the Settlement setting forth (a) the nature of the objection, (b) proof of ownership of Olaplex common stock as of April 24, 2026 and through the date of the Settlement Hearing (including the number of shares of Olaplex common stock held and the date of purchase), (c) any and all documentation or evidence in support of such objection, and (d) the identities of any cases, by name, court, and docket number, in which the shareholder or his, her, or its attorney has objected to a settlement in the last three years; and (2) if intending to appear and requesting to be heard at the Settlement Hearing, he, she, or it must, in addition to the requirements of (1) above, file with the Clerk of the Court and serve on the below counsel (a) a written notice of his, her, or its intention to appear at the Settlement Hearing, (b) a statement that indicates the basis for such appearance, (c) the identities of any witnesses he, she, or it intends to call at the Settlement Hearing and a statement as to the subjects of their testimony, and (d) any and all evidence that would be presented at the Settlement Hearing. Any objector who does not timely file and serve an objection in accordance with this paragraph shall be foreclosed from raising any objection to the Settlement and from objecting at the Settlement Hearing, except for good cause shown.
IF YOU MAKE A WRITTEN OBJECTION, IT MUST BE ON FILE WITH THE CLERK OF THE COURT NO LATER THAN JULY 6, 2026. The Clerk’s address is:
Clerk of the Court
United States District Court for the Central District of California
First Street United States Courthouse
350 W. First Street, 4th Floor
Los Angeles, CA 90012-2111
YOU ALSO MUST DELIVER COPIES OF THE MATERIALS TO PLAINTIFFS’ COUNSEL AND DEFENDANTS’ COUNSEL SO THEY ARE RECEIVED NO LATER THAN JULY 6, 2026. Counsel’s addresses are:
Counsel for Plaintiffs
Timothy Brown
THE BROWN LAW FIRM
767 Third Avenue, Suite 2501
New York, NY 10017
Melissa A. Fortunato
BRAGAR EAGEL & SQUIRE, P.C.
515 S. Flower Street, Suite 1800
Los Angeles, CA 90071
Seth D. Rigrodsky
RIGRODSKY LAW, P.A.
1007 North Orange Street, Suite 453
Wilmington, DE 19801
Counsel for Defendants
Anne Johnson Palmer
ROPES & GRAY LLP
One Maritime Plaza, Suite 1800
300 Clay Street
San Francisco, CA 94111
An objector may file an objection on his, her, or its own or through an attorney hired at his, her, or its own expense. If an objector hires an attorney to represent him, her, or it for the purposes of making such objection, the attorney must serve (either by hand delivery or by first class mail) a notice of appearance on the counsel listed above and file such notice with the Court no later than twenty-one (21) days before the Settlement Hearing. Any Olaplex shareholder who does not timely file and serve a written objection complying with the above terms shall be deemed to have waived, and shall be foreclosed from raising, any objection to the Settlement, and any untimely objection shall be barred.
Any objector who files and serves a timely, written objection in accordance with the instructions above, may appear at the Settlement Hearing either in person or through counsel retained at the objector’s expense. Objectors need not attend the Settlement Hearing, however, in order to have their objections considered by the Court.
If you are a Current Olaplex Shareholder and do not take steps to appear in this action and object to the proposed Settlement, you will be bound by the Judgment of the Court and will forever be barred from raising an objection to such settlement in this or any other action or proceeding, and from pursuing any of the Released Claims.
If you held Olaplex common stock as of April 24, 2026 and continue to hold such stock, you may have certain rights in connection with the proposed Settlement.
CURRENT OLAPLEX STOCKHOLDERS AS OF APRIL 24, 2026 WHO HAVE NO OBJECTION TO THE SETTLEMENT DO NOT NEED TO APPEAR AT THE SETTLEMENT HEARING OR TAKE ANY OTHER ACTION.
Interim Stay and Injunction
Pending the Court’s determination as to final approval of the Settlement, the Plaintiffs and all other Olaplex shareholders, derivatively on behalf of Olaplex, are barred and enjoined from commencing, prosecuting, instigating, continuing, or in any way participating in the commencement or prosecution of any action asserting any of Plaintiffs’ Released Claims derivatively against any of Defendants’ Released Persons.
You may obtain further information by contacting counsel for Plaintiffs at: Timothy Brown, The Brown Law Firm, 767 Third Avenue, Suite 2501, New York, NY 10017, Email: [email protected]; or Melissa A. Fortunato, Bragar, Eagel, & Squire, P.C., 515 S. Flower Street, Suite 1800, Los Angeles, CA 90071, Email: [email protected]; or Seth D. Rigrodsky, Rigrodsky Law, P.A., 1007 North Orange Street, Suite 453, Wilmington, DE 19801. Please Do Not Call the Court or Defendants with Questions About the Settlement.
Dated: May 29, 2026
BY ORDER OF THE UNITED STATES DISTRICT COURT OF THE CENTRAL DISTRICT OF CALIFORNIA
About OLAPLEX
OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX’s award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
Contacts:
Investors:
Michael Oriolo
Vice President, Strategy & Investor Relations [email protected]
Financial Media:
Lisa Bobroff
Vice President, Global Communications & Consumer Engagement [email protected]
_____________________
i A derivative action is an action brought by a shareholder on behalf of a company, rather than on behalf of himself or herself or the other shareholders of the company. The recovery sought in a derivative action is for the benefit of the company rather than directly for individual shareholders.
ii All capitalized terms used in this Notice, unless otherwise defined below, have the same meanings used in the Stipulation.
